3. Title Vaccination and immunisation data return collected through the COVER

Transcription

1 1. Record Type? 2. Unique Number Reassessment R Title Vaccination and immunisation data return collected through the COVER 4. Collection Type National 5. Other Reference 6. Description Cover of Vaccination Evaluated Rapidly (COVER) is a national mandated data collection that is used to evaluate the routine (and some selective) childhood immunisation programme in England for children up to 5 years of age. The aim is to collect and report vaccine coverage data for all children at one, two and five years of age on a quarterly and annual basis. Coverage measurement is dependent on having an accurate eligible population (denominator) and a robust method of ascertaining the number of those eligible individuals who have received a particular vaccine dose (numerator). Vaccination records are held in Child Health Information Systems (CHIS) that operate at the local level, and are commissioned by NHS England and managed by child health record departments (CHRDs) based in acute or community healthcare trusts. These departments are responsible for maintaining active and accurate child health records for a given local population. Section 7A Service Specification 28 defines the minimum standards for CHIS which includes the continued reporting of data by LA responsible population until the functionality defined in the Output Based Specification can be achieved. Quarterly and annual returns are

2 submitted by CRHD or other local providers to PHE National Infection Service Centre for Infectious Disease Surveillance and Control. This information is promptly fed back to the local level, creating the opportunity to improve coverage and to detect changes in vaccine coverage quickly. PHE is mandated to report on vaccine coverage figures as official statistics for children aged one, two and five years for the Local Authority (upper tier) responsible population for the Public Health Outcomes Framework (PHOF) indicator 3.3. Population vaccination coverage. NHS Digital is mandated to report on the annual COVER data as national statistics. COVER statistics enable to monitor the contribution of the routine childhood immunisation programme towards protecting and improving the nation s health and are used to address inequalities. PHE and the DH also have commitments to report vaccine coverage figures to international organisations such as the World Health Organization, and the European Centre for Disease Prevention and Control. 7. State Submitted to BAAS 8. BAAS Reference No SCCI 0089 Amd 8/2014 Change 9. Start Date 01/01/ End Date 31/12/ FT Collection Type 12. Collection Type NOT REQUIRED MANDATORY

3 13. Owning Organisation 14. Owning Department 15. Owner Name and Contact Details Public Health England Immunisation, Hepatitis and Blood Safety Name: Joanne White Tel No: Location: Immunisation, Hepatitis and Blood Safety Department, Centre for Infectious Disease Surveillance and Control (CIDSC), National Infection Service, Public Health England, 61 Colindale Avenue, LONDON NW9 5EQ 16. Senior Supporting Official Name 17. Senior Supporting Official Contact Details Professor Nick Phin, Director CIDSC Title: Dr Michael Edelstein Tel No: Location: Immunisation, Hepatitis and Blood Safety Department, CIDSC, National Infection Service, Public Health England, 61 Colindale Avenue, LONDON NW9 5EQ 18. Data Provider - Burden Days

4 18. Data Provider - Burden 18. Frequency 18. Source Organisation s (Number of orgs) 19. Set Up Costs 20. Other Costs 21. Total Costs 22. Please explain the reason for any increase or decrease in burden and provide details of the any other costs figure provided in Q Quarterly Acute Non Foundation Trust (70), () From April 2013 following the reorganisation of the NHS, Public Health England (PHE) is mandated to report COVER statistics by Local Authority (upper tier) resident population for the PHOF. However, due to the current limitations of CHIS IT infrastructure, Local Authority (LA) responsible population has been the only geography requested since April The requirement specified in the previous ISN to collect vaccination coverage data at LA (upper tier) resident population has been removed. This has reduced the burden for data providers as only one geographical breakdown is required. 2. The new NHS England Healthy Children: transforming child health information strategy aims to transform child health information services by making these systems interoperable, reducing the administrative burden of information recording and sharing. Part of this programme includes merging CHIS systems into

5 local hubs that can provide COVER data for several LAs in one submission. The number of CHIS systems has decreased from over 100 in 2015 to around 70 by mid The burden has therefore decreased accordingly and will decrease further as this programme progresses. 23. Benefits to Patients and the NHS 24. Financial benefits to running this collection 25. Publication methods The ability to reliably measure vaccine coverage plays an essential role in evaluating the success of a vaccination programme, identifying susceptible populations for further interventions and informing future vaccine policy decisions. The COVER programme in England monitors immunisation coverage data for children who reach their first, second or fifth birthday during each evaluation quarter. This information is promptly fed back to local level, creating the opportunity to improve coverage and to detect changes in vaccine coverage quickly. The COVER return monitors whether age dependent vaccinations have been given in a timely manner and promotes equal access to care services by providing coverage data for all geographical areas. These data are also used by the MHRA and in combination with data on adverse outcomes are used to monitor Vaccine Safety. Maintaining high vaccine coverage in all areas will prevent cases and outbreaks of vaccine preventable diseases and the associated costs. The financial benefits from a societal perspective include the disease morbidity and mortality prevented i.e. DALYs and QALYs gained, and from an NHS perspective include savings to the NHS such as GP consultations, A+E attendances and admissions averted. Quarterly UK COVER reports and local level data are published on the PHE website as official statistics. Annual COVER data are published as national statistics by NHS Digital

6 26. Publication Links 27. Requesting Organisation 28. Collection Method 29. NHS Mandate Commitment 30. Changes since last assessment -uptake#cover-of-vaccination-evaluated-rapidlyprogramme Public Health England , Extract from existing NHS systems, Other electronic (e.g. spreadsheet or disk), Database extract These data are required as sub-indicators and baseline data for the Public Health Outcomes Framework (PHOF) Section 3.3 Population vaccination coverage (Health Protection) 1. From April 2013 following the reorganisation of the NHS, Public Health England (PHE) is mandated to report COVER statistics by Local Authority (upper tier) resident population for the PHOF. However, due to the current limitations of CHIS IT infrastructure, Local Authority (LA) RESPONSIBLE population has been the only geography requested since April The requirement specified in the previous ISN to collect vaccination coverage data at LA (upper tier) RESIDENT population is therefore not currently implemented and has been removed. 2. The Meningitis C vaccination schedule was changed and from 1st July 2016 the dose in the first year of life has been removed. COVER data will no longer collect MenC at 12 months and has been removed from the request parameters and the template. 3. Meningitis B vaccination was added to the immunisation schedule in September 2015; the primary course is two doses offered at eight and sixteen weeks with a booster dose at 12 months. In August 2016, MenB vaccination data flow was

7 activated (as indicated in Change Request published in November 2014), and the definitions for calculating 12 month and 24 month vaccine coverage for MenB were added to the COVER user guide. 4. From October 2017 the pentavalent vaccine (DTaP/IPV/Hib) used for the primary course and offered at 8, 12 and 16 weeks, will be replaced with a hexavalent vaccine (DTaP/IPV/Hib/HepB) offering protection against hepatitis B. 5. High risk babies born to hepatitis B surface antigen positive mothers will still be required to receive monovalent HepB vaccine at birth, 4 weeks and 12 months of age in addition to the routine primary hexavalent vaccine. This means these babies will now be scheduled to receive up to 6 doses of a HepBcontaining vaccine by 13 months. 31. Data in operational systems 32. Plans for collecting this data from operational systems 33. If the data was not collected, what would the consequence s be Yes Quarterly and annual datasets have been collected since 1995 through the COVER programme. This reassessment is a continuation of the programme. Without the revisions in this reassessment COVER will be unable to continue to accurately assess the routine primary vaccines offered in the first year of life nor the selection neonatal hepatitis B programme 34. Is there an impact assessment or business

8 case for this collection? If so please attach 35. Process required for others to go through to obtain the data Data are published in excel format on PHE website where they can be downloaded freely 36. Keywords coverage, vaccine, immunisation 37. National / Official statistic National, Official 38. Method used to store the data 39. Why sampling is not used 40. Details of any pilots 41. Equalities dimensions used in the collection Vaccine coverage is required to be monitored by every area of the country to ensure that there are no pockets of poor coverage where outbreaks of vaccine preventable disease could occur Quarterly COVER data collections have been conducted since 1987 and as a formal ROCR submission since The current format has been used for collections in the last decade. We have based the estimate above on our experience over the past 30 years. Age/Date of Birth

9 42. Policy that the collection supports 43. IG Data type Vaccine coverage data was used to inform the decision to conduct a national MMR catch-up programme in April The 30-year time series of COVER data have been used in the national Measles and Rubella Elimination Group to determine which birth cohorts still have susceptibility levels above those required to eliminate these infections and COVER data are also presented regularly at the Joint Committee on Vaccination and Immunisation (JCVI) meetings Aggregate